Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Evaluation of the Effects of Levodopa-Benserazide Drug Combination on Periodontal Status in Patients With Parkinson's Disease

Trial N/A Active, not recruiting Sept. 3, 2026

A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease

Trial Phase 2 Active, not recruiting Sept. 3, 2026

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

Trial N/A Recruiting Sept. 3, 2026

Real-world Patient Experiences With Inbrija®

Trial N/A Not yet recruiting Sept. 3, 2026

Impact of Subthalamic Nucleus Deep Brain Stimulation on COGnitive and PSYchiatric Symptoms in Parkinson's Disease

Trial N/A Recruiting Sept. 3, 2026

Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy

Trial N/A Enrolling by invitation Sept. 2, 2026

Neurofeedback Rehabilitation With FES and VR for PD

Trial N/A Completed Sept. 2, 2026

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Trial N/A Recruiting Sept. 2, 2026

Split-belt Treadmill Training for Freezing of Gait in Parkinson's Disease

Trial N/A Completed Sept. 2, 2026

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Trial Phase 3 Recruiting Sept. 2, 2026

VG081821AC Tablets for Early to Mid-stage Parkinson's Disease

Trial Phase 2 Recruiting Sept. 2, 2026

Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease

Trial Phase 2 Completed Sept. 2, 2026

Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease

Trial Phase 2 Active, not recruiting Sept. 2, 2026

Physiology, Imaging and Modeling of Essential Tremor

Trial N/A Completed Sept. 2, 2026

Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis

Trial Phase 2 Recruiting Sept. 2, 2026

Cortical Electrophysiology of Response Inhibition in Parkinson's Disease

Trial Phase 4 Recruiting Sept. 2, 2026

Connectomic Guided DBS for Parkinson's Disease

Trial N/A Enrolling by invitation Sept. 2, 2026

Anodic Stimulation in Parkinson's Disease

Trial N/A Active, not recruiting Sept. 1, 2026

The GBA Multimodal Study in Parkinson's Disease

Trial N/A Completed Sept. 1, 2026

Sensor-Based Optimization of Therapy for Parkinson's Disease Patients With Motor Fluctuations

Trial N/A Not yet recruiting Sept. 1, 2026